Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -152,148 | -95,990 | -89,056 | -32,609 | -53,413 |
| Depreciation Amortization | -8,057 | -4,086 | -846 | 176 | 251 |
| Accounts payable and accrued liabilities | -3,453 | -873 | 10,606 | 475 | 567 |
| Other Working Capital | 2,660 | -5,822 | 6,747 | 3,511 | 123 |
| Other Operating Activity | 26,319 | 14,590 | 4,953 | 4,739 | 17,663 |
| Operating Cash Flow | $-134,679 | $-92,181 | $-67,596 | $-23,708 | $-34,809 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -972 | -63 | -62 | -5,000 | -42 |
| Purchase Of Investment | -703,015 | -224,930 | -148,490 | N/A | N/A |
| Sale Of Investment | 278,958 | 185,562 | 78,000 | 796 | N/A |
| Investing Cash Flow | $-425,029 | $-39,431 | $-70,552 | $-4,204 | $-42 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 24,741 | 19,816 | 4,921 | 5,602 |
| Debt Repayment | N/A | N/A | N/A | N/A | -130 |
| Common Stock Issued | 645,913 | 116,056 | 88,214 | 51,726 | 230 |
| Common Stock Repurchased | -13 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -39,227 | -7,256 | -6,097 | -2,765 | 79,588 |
| Financing Cash Flow | $606,673 | $133,541 | $101,933 | $53,882 | $85,290 |
| Beginning Cash Position | 45,681 | 43,752 | 79,967 | 53,997 | 3,558 |
| End Cash Position | 92,646 | 45,681 | 43,752 | 79,967 | 53,997 |
| Net Cash Flow | $46,965 | $1,929 | $-36,215 | $25,970 | $50,439 |
| Free Cash Flow | |||||
| Operating Cash Flow | -134,679 | -92,181 | -67,596 | -23,708 | -34,809 |
| Capital Expenditure | -972 | -63 | -62 | -5,000 | -99 |
| Free Cash Flow | -135,651 | -92,244 | -67,658 | -28,708 | -34,908 |